A patient is ineligible for mechanical thrombectomy beyond 6 hours when imaging shows a large established infarct core that has likely irreversibly destroyed the salvageable tissue—typically an Alberta Stroke Program Early CT Score (ASPECTS) of 5 or less on non-contrast CT, or a large core on perfusion imaging—because opening the vessel would expose the patient to hemorrhage and reperfusion injury without meaningful chance of functional recovery. In practice, the single most decisive disqualifier is a core volume that exceeds the trial-validated ceiling for late-window treatment, generally above roughly 70 mL in the 6–24 hour window.
The core-infarct ceiling
Late-window thrombectomy works because a blocked large vessel leaves a column of brain tissue—the ischemic penumbra—alive but starving, sustained by collateral flow. The tissue that has already died is the core. The therapeutic bet is that restoring flow rescues penumbra before it joins the core. When the core is already large, that bet fails.
The mechanism is a matter of plumbing and time. A large-vessel occlusion drops perfusion pressure downstream. Collateral vessels from adjacent territories partially compensate, but they deliver less blood than the tissue needs. Cells in the core die within minutes; cells in the penumbra die over hours. The later the clock, the more penumbra has converted to core. By 6–24 hours, some patients still have substantial penumbra and a small core, and those are the ones who benefit. Others have a core so large that little or no salvageable tissue remains.
Opening an occluded artery in a brain with a large completed infarct does not restore function in dead tissue. It re-exposes a damaged vascular bed to full perfusion pressure, which promotes hemorrhagic transformation and cerebral edema. The clinical consequence is that the risk of symptomatic intracranial hemorrhage and malignant swelling rises while the chance of a good functional outcome falls toward zero.
Quantified context: numbers that decide eligibility
The late-window trials defined eligibility with specific imaging thresholds, and those thresholds anchor real-world decisions. The DAWN trial enrolled patients 6–24 hours from last known normal with a clinical-imaging mismatch; a typical qualifying profile was a small core and a substantial neurological deficit. The DEFUSE 3 trial, covering 6–16 hours, required an initial infarct core of less than 70 mL and a ratio of penumbral to core tissue of at least 1.8. These are concrete numbers, not abstractions.
A core above 70 mL in that window was excluded from DEFUSE 3. That figure is not a universal law of biology; it is the boundary the trial evidence supports. Many centers now treat roughly 50–70 mL as the practical ceiling for late-window selection, and some extend cautiously with advanced imaging. The point is that the disqualifying condition is a core that is too large relative to the surviving penumbra, and the validated numeric proxy is an infarct core beyond about 70 mL or an ASPECTS of 5 or less.
ASPECTS is a 10-point scoring system on non-contrast CT; each point lost represents an region of established ischemic change. A score of 6 or higher generally supports treatment in the late window, while 5 or lower signals a core large enough to make benefit unlikely and harm plausible.
Timeline of tissue fate beyond 6 hours
| Time from last known normal | Typical core behavior | Selection implication |
|---|---|---|
| 0–6 hours | Core small, penumbra large in most LVO patients | Standard window; imaging still guides but time dominates |
| 6–9 hours | Core enlarging; mismatch often preserved | Late-window imaging required; core under 70 mL favors treatment |
| 9–12 hours | Core conversion accelerates; mismatch narrower | Careful perfusion selection; large core disqualifies |
| 12–16 hours | DEFUSE 3 upper bound; core ceiling applied | Core over 70 mL or poor mismatch means ineligible |
| 16–24 hours | DAWN-type clinical-imaging mismatch only | Small core plus meaningful deficit required |
| Beyond 24 hours | Evidence base largely absent | Individualized; generally outside trial-supported eligibility |
The table reflects trial design boundaries, not biological absolutes. A patient at 14 hours with a 30 mL core and a large penumbra may still qualify; a patient at 8 hours with an 80 mL core generally will not. The condition that deems the patient ineligible is the imaging finding, not the clock alone.
Edge cases that complicate the call
Several situations blur the core-ceiling rule. A patient with a large core but a devastating deficit and no realistic alternative may still be considered at some centers, though outside standard eligibility. Conversely, a small core with a poor collateral profile may deteriorate faster than imaging predicts.
Counterintuitive detail: a very low ASPECTS does not always mean the patient is beyond help in every scenario. Some recent evidence suggests selected patients with larger cores may still benefit from thrombectomy, which is why the field is actively re-examining the 70 mL ceiling. But in the standard late-window framework the question invokes, a large established core remains the disqualifying condition.
Another edge case is the patient with an unknown or unreliable last known normal. If the time cannot be established, late-window imaging criteria still apply, but the uncertainty itself can push a borderline case toward ineligibility when the core is already large.
Misconceptions worth correcting
The most common misconception is that time alone determines eligibility beyond 6 hours. It does not. The 6-hour mark is a boundary between trial frameworks, not a biological switch. A patient at 7 hours with a massive core is ineligible; a patient at 20 hours with a small core and clinical mismatch may qualify.
A second misconception is that a normal non-contrast CT means the patient is eligible. A normal-appearing CT can still hide a large perfusion core, and conversely an obvious large hypodensity signals established infarction that disqualifies.
A third misconception is that opening the vessel is always better than leaving it closed. In a large completed infarct, reperfusion can worsen edema and hemorrhage without restoring function. The professional caveat is that eligibility is a risk-benefit judgment, and a large core tips the balance against treatment.
Practical actions and thresholds
When a patient presents beyond 6 hours from last known normal with a suspected large-vessel occlusion, the workflow is imaging-driven.
Obtain non-contrast CT immediately to calculate ASPECTS; a score of 5 or less generally flags a core too large for standard late-window treatment. Obtain CT perfusion or MR perfusion to measure core volume and penumbral mismatch; a core above roughly 70 mL in the 6–16 hour window is the trial-validated disqualifier. Confirm a large-vessel occlusion by CT angiography; thrombectomy targets large vessels, so absence of LVO removes the indication regardless of core size. Reconcile the timelines: DAWN supports 6–24 hours with clinical-imaging mismatch, DEFUSE 3 supports 6–16 hours with core under 70 mL and mismatch ratio at least 1.8. Escalate borderline cases to a stroke neurologist or neurointerventionalist rather than applying a single number mechanically. Red flag: a large hypodensity on non-contrast CT, a core above 70 mL, or ASPECTS of 5 or less beyond 6 hours signals ineligibility under standard criteria.
The plain-language version: if too much brain is already dead, reopening the artery cannot bring it back and may cause bleeding, so the patient is not a candidate.
Limitations of the evidence
The numeric thresholds come from specific trials with specific enrollment criteria, and real patients often fall between categories. The 70 mL core ceiling is a trial boundary, not a measured biological constant, and imaging software varies between vendors. Guideline recommendations continue to evolve as newer trials test larger-core treatment. What can be concluded is stable: a large established infarct core is the condition that most reliably deems a late-window patient ineligible, because it removes the salvageable tissue that makes thrombectomy worthwhile and raises the risk of hemorrhage and edema. This article is general educational information, not a diagnosis or treatment plan. Eligibility decisions require a qualified stroke team and local protocols; for immediate neurological emergency, contact local emergency services.